New York Seeks the “Select Experts” for Its Rare Disease Advisory Council: Rare Voices, Rare Seats
National Organization for Rare Disorders (NORD) recently shared an inviting post to Rare Disease Advisory Council on X:
”Join the New York State Rare Disease Advisory Council!
Are you a healthcare professional, researcher, caregiver, patient, or advocate passionate about Rare Diseases? New York State is establishing the Rare Disease Advisory Council to continue the important work launched by the Rare Disease Workgroup under Article 27-L of the Public Health Law (2021).
We’re looking for individuals from across New York to bring diverse perspectives and lived experiences to this effort. Help shape policies that support and elevate the voices of New Yorkers impacted by rare diseases.”
To submit your application, follow the link.
Calling all healthcare professionals, researchers, caregivers, and patients — if your connection to rare diseases puts you in that unique minority, New York wants you to join its newly formed Rare Disease Advisory Council.
Built on the foundations of Article 27-L of the Public Health Law, this council promises to elevate patient voices — assuming they can squeeze into policy meetings.
Applications now open for those ready to shape big decisions in small, infrequent doses!
To not miss opportunities in the field of your expertise, read Hemostasis Today, daily!
-
Oct 11, 2025, 09:06Natalia Peres Martinez - Surgical Bleed: Replacing Gut Feeling With Guided Thinking
-
Oct 11, 2025, 09:00Muhammad Ali - Hematology In Pakistan: The Silent Revolution In Diagnosis And A Blueprint For Growth
-
Oct 11, 2025, 08:50Robert Zeiser: New Insights and Timeless Lessons in Transplantation
-
Oct 11, 2025, 08:39Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
-
Oct 11, 2025, 08:33RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
-
Oct 11, 2025, 18:47Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
-
Oct 11, 2025, 08:49Rodrigo Assar: We Are Pushing the Boundaries by Using Computational Approaches
-
Oct 11, 2025, 08:48Deborah Wild: Thrilled to See GeneVentiv Selected for The NIH NHLBI Catalyze Program
-
Oct 11, 2025, 08:34Ivo Francischetti and Colleagues on Glycoprotein VI Contributing to Platelet Activation in HIT
-
Oct 11, 2025, 08:00Michael Hadley: Photon-Counting CT Offers Good Diagnostic Accuracy for Detecting In-Stent Restenosis
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 11, 2025, 08:57Jeff June - Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
-
Oct 11, 2025, 08:11Khaled Musallam: Honored to Be Featured for The 7th Year in A Row in The World’s Top 2% Most-Cited Scientists
-
Oct 11, 2025, 08:07Britta Diebel: This Has Been An Intense, Good Week, Although IPAW Actually Lasts All Year Long
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?